DOCTORATE in GENETICS, ONCOLOGY and CLINICAL MEDICINE (GenOMeC)
DOTTORATO DI RICERCA IN GENETICA ONCOLOGIA E MEDICINA CLINICA

UNIVERSITA' DEGLI STUDI  DI SIENA

                                                                                        Home Page

 

Abstracts of Conference during the PhD program

 
Forte Iris Maria
 

1- A miRNA expression profiling identifies mir-14 as a key player in human malignant pleural mesothelioma (Congresso internazionale GOIM, Brindisi, Italia, 20-23/6/2010)PUB

2- Small molecules mimicking the spa310 peptide from the spacer region of pRB2/p130 as potential anticancer agents (Fifth Annual Scientific Conference ITT, Il Borro. San Giustino Valdarno ,Italia, 1/7/2010)

 

 

3- 3- Studi preliminari dell’espressione di pRb2/p130 e della Ciclina A2 nel carcinoma gastrico (Update in tema di Anatomia patologia e ricaduta clinica, Imperial Hotel Tramontano , Sorrento 27-29 Maggio 2011)

4- A selective cdk inhibitor mimicking the spa310 as a potential anticancer agent.( 130  Congresso Nazionale del Goim “Trattamenti innovative in Oncologia”. Bari 19-22 Giugno 2011)

5- Pharmacological targeting of p53 effectively induces apoptosis in malignant mesothelioma cell lines. (130  Congresso Nazionale del Goim “Trattamenti innovative in Oncologia”. Bari 19-22 Giugno 2011)

6- New SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.(130  Congresso Nazionale del Goim “Trattamenti innovative in Oncologia”. Bari 19-22 Giugno 2011)

7- New SCR inhibitors induce p27- mediated apoptosis in mesotelioma cell lines (ACCR 10 2nd Annual Meeting 2011)